Main navigation is closed
Dr. Raymond Benza appointed as first Kaufman Academic Chair of Cardiology
Dr. Benza is an internationally recognized leader in cardiology
91制片厂福利视频 announces the appointment of Raymond L. Benza, M.D., as the inaugural George M. and Linda H. Kaufman Academic Chair of Cardiology. Dr. Benza is an internationally recognized leader in advanced heart failure, pulmonary hypertension, cardiac transplantation, and mechanical circulatory support. He brings a distinguished career of academic excellence, translational research, and innovative clinical leadership to 91制片厂福利视频.
Dr. Benza has held key leadership roles at health system, , and , where he built and directed nationally acclaimed cardiovascular programs. His work has significantly advanced the fields of heart failure, pulmonary vascular disease, and cardiology education, with an emphasis on cutting-edge clinical trials and novel treatment approaches.
“Dr. Benza’s expertise and vision are aligned with 91制片厂福利视频’s commitment to advancing academic medicine, pioneering research, and improved patient care and outcomes,” said Michael Hooper, M.D., senior vice president and chief medical and academic officer for 91制片厂福利视频. “We’re confident he will lead our academic cardiology program into a new era of innovation and excellence.”
Dr. Benza has led or supported more than 150 clinical trials in heart failure, pulmonary hypertension, and cardiac transplantation. He has authored or co-authored more than 300 peer-reviewed articles in professional journals. He holds multiple patents related to cardiovascular medical devices, including a groundbreaking catheter for right heart failure. He has conducted pioneering research in risk prediction modeling that led to the international standard for risk stratification in pulmonary hypertension.
Dr. Benza’s national and international collaborations, including leadership roles with the , the , and the , further highlight his impact on the field.
Dr. Benza has held key leadership roles at health system, , and , where he built and directed nationally acclaimed cardiovascular programs. His work has significantly advanced the fields of heart failure, pulmonary vascular disease, and cardiology education, with an emphasis on cutting-edge clinical trials and novel treatment approaches.
“Dr. Benza’s expertise and vision are aligned with 91制片厂福利视频’s commitment to advancing academic medicine, pioneering research, and improved patient care and outcomes,” said Michael Hooper, M.D., senior vice president and chief medical and academic officer for 91制片厂福利视频. “We’re confident he will lead our academic cardiology program into a new era of innovation and excellence.”
Dr. Benza has led or supported more than 150 clinical trials in heart failure, pulmonary hypertension, and cardiac transplantation. He has authored or co-authored more than 300 peer-reviewed articles in professional journals. He holds multiple patents related to cardiovascular medical devices, including a groundbreaking catheter for right heart failure. He has conducted pioneering research in risk prediction modeling that led to the international standard for risk stratification in pulmonary hypertension.
Dr. Benza’s national and international collaborations, including leadership roles with the , the , and the , further highlight his impact on the field.